The Alternative Pathway of Complement — A System for Host Resistance to Microbial Infection
- 31 July 1980
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 303 (5) , 259-263
- https://doi.org/10.1056/nejm198007313030505
Abstract
THE alternative pathway of complement activation is that part of the complement system that can provide natural, nonimmune defense against microbial infection. In the early 1950's, Pillemer and his associates found that if a novel protein termed properdin (derived from the Latin verb perdere, "to destroy") was removed from human serum, certain serum bactericidal, virus-neutralizing, and hemolytic activities that appeared not to require antibody were impaired. These observations attracted great interest in the "properdin system" as a nonimmune mechanism for activating complement that was distinct from the antibody-dependent activation of the classical complement components Cl, C4, and C2. However, an . . .Keywords
This publication has 33 references indexed in Scilit:
- Correlation between levels of breakdown products of C3, C4, and properdin factor b in synovial fluids from patients with rheumatoid arthritisArthritis & Rheumatism, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.The Journal of Experimental Medicine, 1976
- Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.Journal of Clinical Investigation, 1976
- Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.Journal of Clinical Investigation, 1975
- Depressed synovial fluid levels of properdin and properdin factor b in patients with rheumatoid arthritisArthritis & Rheumatism, 1975
- Mechanisms of Immune Lysis of the Red Cells in Hereditary Erythroblastic Multinuclearity with a Positive Acidified Serum Test and Paroxysmal Nocturnal HemoglobinuriaJournal of Clinical Investigation, 1974
- C3 PROACTIVATOR CONVERTASE AND ITS MODE OF ACTIONThe Journal of Experimental Medicine, 1972
- Serum C′3 Lytic System in Patients with GlomerulonephritisScience, 1969
- THE PROPERDIN SYSTEM AND IMMUNITY. IV. THE HEMOLYSIS OF ERYTHROCYTES FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1Journal of Clinical Investigation, 1956